| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...874313S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0074313 |
| P932 | PMC publication ID | 3779201 |
| P698 | PubMed publication ID | 24073208 |
| P5875 | ResearchGate publication ID | 257136569 |
| P50 | author | Wataru Nakata | Q57068752 |
| Kazutoshi Fujita | Q57068763 | ||
| P2093 | author name string | Takahiro Yoshida | |
| Koji Hatano | |||
| Norio Nonomura | |||
| Motohide Uemura | |||
| Hitoshi Takayama | |||
| Yasutomo Nakai | |||
| Atsunari Kawashima | |||
| Mototaka Sato | |||
| P2860 | cites work | Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases | Q22003941 |
| Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis | Q24805089 | ||
| Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production | Q24812313 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts | Q28216628 | ||
| Sunitinib versus interferon alfa in metastatic renal-cell carcinoma | Q28282757 | ||
| The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily | Q28304981 | ||
| Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors | Q29615445 | ||
| Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics | Q29615944 | ||
| What Is the Evidence That Tumors Are Angiogenesis Dependent? | Q29620029 | ||
| RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro | Q33946429 | ||
| Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. | Q33970452 | ||
| Role of emmprin in endometrial cancer | Q34284285 | ||
| Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. | Q35569214 | ||
| Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis | Q35575003 | ||
| Tumor angiogenesis in advanced stage ovarian carcinoma. | Q35796308 | ||
| EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. | Q36076520 | ||
| Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters. | Q53626180 | ||
| Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. | Q55475249 | ||
| Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation | Q69795457 | ||
| Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival | Q71920372 | ||
| 5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina | Q72554209 | ||
| Quantification of angiogenesis by a computerized image analysis system in renal cell carcinoma | Q73369400 | ||
| Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma | Q73739723 | ||
| A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis | Q74311247 | ||
| CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma | Q81935887 | ||
| CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value | Q84110576 | ||
| Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression | Q36515358 | ||
| Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis | Q36611964 | ||
| Vascular endothelial growth factor C induces angiogenesis in vivo. | Q36734917 | ||
| Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors | Q36787960 | ||
| EAU guidelines on renal cell carcinoma: the 2010 update | Q37773064 | ||
| Characterization of an established cell line from human renal carcinoma | Q39280597 | ||
| A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma | Q40200798 | ||
| Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. | Q40400391 | ||
| Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases | Q40434433 | ||
| Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells | Q40552173 | ||
| Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production | Q40585893 | ||
| Expression of emmprin by oral squamous cell carcinoma | Q40903185 | ||
| Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma | Q40933435 | ||
| Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. | Q40983568 | ||
| Expression patterns of emmprin and monocarboxylate transporter-1 in ovarian epithelial tumors | Q42511831 | ||
| Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma | Q43658784 | ||
| Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan | Q44435256 | ||
| How well do angiogenesis inhibitors work? Biomarkers of response prove elusive. | Q45976068 | ||
| Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer | Q46448808 | ||
| Antiangiogenesis research is booming, as questions and studies proliferate | Q47721584 | ||
| HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection | Q47811362 | ||
| Evaluation of microvessel density by computerised image analysis in human renal cell carcinoma. Correlation to pT category, nuclear grade, proliferative activity and occurrence of metastasis | Q47995669 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| renal cell carcinoma | Q1164529 | ||
| P304 | page(s) | e74313 | |
| P577 | publication date | 2013-09-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome | |
| P478 | volume | 8 |
| Q38720430 | A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review |
| Q35004013 | Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature |
| Q112053038 | Advances in Renal Cell Carcinoma Drug Resistance Models |
| Q47402442 | Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease |
| Q38949683 | CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis |
| Q58790703 | Characterisation of the Morphological, Functional and Molecular Changes in Sunitinib-Resistant Renal Cell Carcinoma Cells |
| Q38294622 | Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancer |
| Q33633431 | Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials |
| Q41335207 | Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy |
| Q40219212 | EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts |
| Q38757525 | EMMPRIN, SP1 and microRNA-27a mediate physcion 8-O-β-glucopyranoside-induced apoptosis in osteosarcoma cells |
| Q35833138 | EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF. |
| Q36841347 | Hispidulin induces mitochondrial apoptosis in acute myeloid leukemia cells by targeting extracellular matrix metalloproteinase inducer |
| Q38836365 | Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling |
| Q44398546 | Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data |
| Q38756973 | Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells |
| Q36544390 | MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma |
| Q41672137 | Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma |
| Q40767732 | Physcion induces mitochondria-driven apoptosis in colorectal cancer cells via downregulating EMMPRIN. |
| Q38334611 | Recent aspects of sunitinib therapy in patients with metastatic clear-cell renal cell carcinoma: a systematic review of the literature |
| Q51763292 | Sunitinib resistance in renal cell carcinoma. |
| Q28083416 | The roles of CD147 and/or cyclophilin A in kidney diseases |
| Q34733240 | Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer. |
| Q38953034 | shRNA-mediated EMMPRIN silencing inhibits human leukemic monocyte lymphoma U937 cell proliferation and increases chemosensitivity to adriamycin |
Search more.